Core Viewpoint - The company is actively exploring the application potential of artificial intelligence (AI) and augmented reality (AR) technologies in ophthalmic medical scenarios, collaborating with leading hardware suppliers and research institutions for joint research and investment incubation [1] Financial Performance - In the first half of 2025, the company achieved revenue of 560 million yuan, a year-on-year decrease of 4.22% [1] - The company reported a net profit attributable to shareholders of 44 million yuan, reflecting a year-on-year increase of 84.19% [1] Strategic Initiatives - The company and its affiliate, Shenyang He Eye Industry Group Co., Ltd., have engaged with several industry-leading hardware suppliers and research institutions to explore collaborative research and investment opportunities [1] - The ongoing exploration of AI and AR technologies is not expected to have a significant impact on the company's current main business operations or performance [1]
何氏眼科：密切关注AI和AR在眼科医疗场景中的应用潜力，积极探索孵化有关合作模式